Gold tier: mechanically validated evidence, with its primary source.
168 evidence items · page 2 / 7
6 countriesAs of 05 September 2024, six countries are experiencing sustained human-to-human transmission of mpox: DRC, Burundi, Nigeria, South Africa, Cote d’Ivoire, and Central African Republic.
Afrique du Sud · Burundi · Nigeria · RDCmpoxobserved 05 September 2024Africa CDCdocument of 48 observations
The patient had recurrent postcoital skin eruptions over a previously healed genital scar from the first episode of Mpox, reported during follow-up in 2022.
Nigeriampoxobserved 2022published 2023The American journal of tropical medicine and hygienePubMeddocument of 2 observations
10,000 dosesNigeria received 10,000 doses of the JYNNEOS mpox vaccine in August 2024.
Nigeriampoxobserved August 2024Africa CDCdocument of 147 observations
24 patientsSampling was repeated in 24 patients 2 weeks after monkeypox diagnosis, with 107 samples collected at a median of 19 days (IQR 18–21) from the onset of symptoms.
NigeriampoxHAL · Unilimdocument of 102 observations
24 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, 24 (68.6%) were males.
Nigeriampoxobserved October 21, 2021 to April 30, 2023published 2025The Pan African medical journalPubMeddocument of 11 observations
16 %Of the 160 patients with mpox, 25 (16%) had HIV in Nigeria during the study period from Feb 1, 2022, to Jan 30, 2023.
Nigeriampox · VIH/sidaobserved Feb 1, 2022, to Jan 30, 2023published 2023The Lancet. Infectious diseasesPubMeddocument of 11 observations
20 %In the study conducted in Paris, MPXV was undetectable in blood from about 20% of patients at diagnosis.
NigeriampoxHAL · Unilimdocument of 102 observations
48 %Of the 160 patients with mpox, 70 (48%) were admitted to hospital in Nigeria during the study period from Feb 1, 2022, to Jan 30, 2023.
Nigeriampoxobserved Feb 1, 2022, to Jan 30, 2023published 2023The Lancet. Infectious diseasesPubMeddocument of 11 observations
The shared ancestor of the zoonotic outgroup and hMPXV-1 circulated in animals in southern Nigeria in late 2013.
Nigeriampoxobserved late 2013published 2025Natureeurope_pmcdocument of 5 observations
27.9 %27.9% (24/86) of confirmed mpox cases were coinfected with HIV.
Nigeriampox · VIH/sidaobserved 2017-2019published 2023BMJ global healthPubMeddocument of 11 observations
45 odds_ratioMpox cases had an odds ratio of 45 for HIV coinfection compared with an age-, gender-, and geography-matched control group from the general population.
Nigeriampox · VIH/sidaobserved 2017-2019published 2023BMJ global healthPubMeddocument of 11 observations
95 %At D14, MPXV tests were negative or weakly positive for 20 (95%) of 21 urine samples.
NigeriampoxHAL · Unilimdocument of 102 observations
In the study series, MPXV was undetectable in urine from more than half of patients at diagnosis.
NigeriampoxHAL · Unilimdocument of 102 observations
105 genomesPhylodynamic reconstruction was performed on 105 Nigerian MPXV genomes.
Nigeriampoxpublished 2026Nature communicationseurope_pmcdocument of 3 observations
0 %At day 14, MPXV detection was observed in 0 (0%) of 14 urine samples.
NigeriampoxHAL · Unilimdocument of 102 observations
20 %In the study series, MPXV was undetectable in blood from about 20% of patients.
NigeriampoxHAL · Unilimdocument of 102 observations
44 %Among 50 men with confirmed monkeypox virus infection, 22 (44%) were classified as HIV-negative on day 0.
Nigeriampox · VIH/sidaHAL · Unilimdocument of 102 observations
59 %Of the 160 patients with mpox, 94 (59%) had a distinct febrile prodrome in Nigeria during the study period from Feb 1, 2022, to Jan 30, 2023.
Nigeriampoxobserved Feb 1, 2022, to Jan 30, 2023published 2023The Lancet. Infectious diseasesPubMeddocument of 11 observations
20.9 CtMPXV viral load was higher in anal samples (Ct 20·9) than from throat samples (Ct 27·2).
NigeriampoxHAL · Unilimdocument of 102 observations
27 %Children under 5 years make up 27% of the mpox-affected population in Nigeria.
NigeriampoxAfrica CDCdocument of 147 observations
9 %At day 14, MPXV detection was observed in 2 (9%) of 11 semen samples.
NigeriampoxHAL · Unilimdocument of 102 observations
9 %At day 14, MPXV detection in semen was two [9%] of 11.
Nigeriampoxobserved day 14HAL · Unilimdocument of 102 observations
3 yearshMPXV-1 circulated undetected for three years after emerging in August 2014.
Nigeriampoxpublished 2025Natureeurope_pmcdocument of 5 observations
Five countries — DRC, Rwanda, Uganda, Central African Republic and Nigeria — are currently vaccinating against mpox.
Nigeria · Ouganda · RDC · Rwandampoxobserved January-February 2025Africa CDCdocument of 72 observations
82 %At D14, MPXV tests were negative or weakly positive for nine (82%) of 11 semen samples.
NigeriampoxHAL · Unilimdocument of 102 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.